381 related articles for article (PubMed ID: 28338748)
1. Role of scavenger receptors as damage-associated molecular pattern receptors in Toll-like receptor activation.
Komai K; Shichita T; Ito M; Kanamori M; Chikuma S; Yoshimura A
Int Immunol; 2017 Feb; 29(2):59-70. PubMed ID: 28338748
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.
Yu M; Wang H; Ding A; Golenbock DT; Latz E; Czura CJ; Fenton MJ; Tracey KJ; Yang H
Shock; 2006 Aug; 26(2):174-9. PubMed ID: 16878026
[TBL] [Abstract][Full Text] [Related]
3. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis.
Bowdish DM; Sakamoto K; Kim MJ; Kroos M; Mukhopadhyay S; Leifer CA; Tryggvason K; Gordon S; Russell DG
PLoS Pathog; 2009 Jun; 5(6):e1000474. PubMed ID: 19521507
[TBL] [Abstract][Full Text] [Related]
4. HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production.
Chen X; Li L; Khan MN; Shi L; Wang Z; Zheng F; Gong F; Fang M
Innate Immun; 2016 Nov; 22(8):696-705. PubMed ID: 27670944
[TBL] [Abstract][Full Text] [Related]
5. High-mobility group box 1 inhibits gastric ulcer healing through Toll-like receptor 4 and receptor for advanced glycation end products.
Nadatani Y; Watanabe T; Tanigawa T; Ohkawa F; Takeda S; Higashimori A; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
PLoS One; 2013; 8(11):e80130. PubMed ID: 24244627
[TBL] [Abstract][Full Text] [Related]
6. Anti-High Mobility Group Box 1 Neutralizing-Antibody Ameliorates Dextran Sodium Sulfate Colitis in Mice.
Chen L; Li J; Ye Z; Sun B; Wang L; Chen Y; Han J; Yu M; Wang Y; Zhou Q; Seidler U; Tian D; Xiao F
Front Immunol; 2020; 11():585094. PubMed ID: 33193406
[TBL] [Abstract][Full Text] [Related]
7. High mobility group box 1 protein interacts with multiple Toll-like receptors.
Park JS; Gamboni-Robertson F; He Q; Svetkauskaite D; Kim JY; Strassheim D; Sohn JW; Yamada S; Maruyama I; Banerjee A; Ishizaka A; Abraham E
Am J Physiol Cell Physiol; 2006 Mar; 290(3):C917-24. PubMed ID: 16267105
[TBL] [Abstract][Full Text] [Related]
8. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor.
Hreggvidsdóttir HS; Lundberg AM; Aveberger AC; Klevenvall L; Andersson U; Harris HE
Mol Med; 2012 Mar; 18(1):224-30. PubMed ID: 22076468
[TBL] [Abstract][Full Text] [Related]
9. High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.
Nadatani Y; Watanabe T; Tanigawa T; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Arakawa T
Am J Pathol; 2012 Jul; 181(1):98-110. PubMed ID: 22634181
[TBL] [Abstract][Full Text] [Related]
10. HMGB1-Driven Inflammation and Intimal Hyperplasia After Arterial Injury Involves Cell-Specific Actions Mediated by TLR4.
Cai J; Yuan H; Wang Q; Yang H; Al-Abed Y; Hua Z; Wang J; Chen D; Wu J; Lu B; Pribis JP; Jiang W; Yang K; Hackam DJ; Tracey KJ; Billiar TR; Chen AF
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2579-93. PubMed ID: 26515416
[TBL] [Abstract][Full Text] [Related]
11. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia.
Qiu J; Xu J; Zheng Y; Wei Y; Zhu X; Lo EH; Moskowitz MA; Sims JR
Stroke; 2010 Sep; 41(9):2077-82. PubMed ID: 20671243
[TBL] [Abstract][Full Text] [Related]
13. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
Qin YH; Dai SM; Tang GS; Zhang J; Ren D; Wang ZW; Shen Q
J Immunol; 2009 Nov; 183(10):6244-50. PubMed ID: 19890065
[TBL] [Abstract][Full Text] [Related]
14. HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease.
Chandrashekaran V; Seth RK; Dattaroy D; Alhasson F; Ziolenka J; Carson J; Berger FG; Kalyanaraman B; Diehl AM; Chatterjee S
Redox Biol; 2017 Oct; 13():8-19. PubMed ID: 28551086
[TBL] [Abstract][Full Text] [Related]
15. High-mobility group box-1 mediates toll-like receptor 4-dependent angiogenesis.
Lin Q; Yang XP; Fang D; Ren X; Zhou H; Fang J; Liu X; Zhou S; Wen F; Yao X; Wang JM; Su SB
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1024-32. PubMed ID: 21372296
[TBL] [Abstract][Full Text] [Related]
16. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
[TBL] [Abstract][Full Text] [Related]
17. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.
van Zoelen MA; Yang H; Florquin S; Meijers JC; Akira S; Arnold B; Nawroth PP; Bierhaus A; Tracey KJ; van der Poll T
Shock; 2009 Mar; 31(3):280-4. PubMed ID: 19218854
[TBL] [Abstract][Full Text] [Related]
18. High-mobility group box-1 and its receptors contribute to proinflammatory response in the acute phase of spinal cord injury in rats.
Chen KB; Uchida K; Nakajima H; Yayama T; Hirai T; Rodriguez Guerrero A; Kobayashi S; Ma WY; Liu SY; Zhu P; Baba H
Spine (Phila Pa 1976); 2011 Dec; 36(25):2122-9. PubMed ID: 21343866
[TBL] [Abstract][Full Text] [Related]
19. Tissue damage negatively regulates LPS-induced macrophage necroptosis.
Li Z; Scott MJ; Fan EK; Li Y; Liu J; Xiao G; Li S; Billiar TR; Wilson MA; Jiang Y; Fan J
Cell Death Differ; 2016 Sep; 23(9):1428-47. PubMed ID: 26943325
[TBL] [Abstract][Full Text] [Related]
20. High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and Receptor for Advanced Glycation End Products.
Mazarati A; Maroso M; Iori V; Vezzani A; Carli M
Exp Neurol; 2011 Dec; 232(2):143-8. PubMed ID: 21884699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
